Samsung Eyes Investment in Exo's $100M Funding Round
Samsung Ventures is considering a substantial investment in Exo, a California-based startup known for its portable ultrasound devices. This potential investment is part of a $100 million funding round, which is being led by Sands Capital, Bold Capital, and Qubit Health Capital, reports TechCrunch.
Exo, founded in 2015, develops handheld medical imaging devices that integrate artificial intelligence, medical imaging, and silicon technology. These devices connect to smartphones, allowing medical professionals to conduct ultrasound examinations and share results via a mobile app. The company has already raised over $320 million from investors such as RA Capital Management, BlackRock, Intel, and Sony.
In addition to the investment, Exo is in discussions with Samsung Medison Co., a subsidiary of Samsung specializing in medical ultrasound and digital radiography systems, to explore potential partnerships.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Funding
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more